Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Humana-Kindred Deal Keeps Shakeout Alive In Healthcare Space By Zacks Investment Research - Dec 20, 2017

Health insurer Humana Inc. (NYSE:HUM) has signed an agreement to acquire Kindred-at-Home, a unit of Kindred Healthcare Inc.Details of the DealTPG Capital and Welsh, Carson, Anderson & Stowe and...

Zacks Investment Research
5 Industrial Stocks That Popped More Than 50% In 2017 By Zacks Investment Research - Dec 20, 2017

In terms of market performance, 2017 has been a significantly good year for the United States. Major stock indexes of the world’s largest economy performed well including the S&P 500, Nasdaq...

Zacks Investment Research
5 Chemical Growth Stocks To Revitalize Your Portfolio In 2018 By Zacks Investment Research - Dec 20, 2017

The chemical industry has gotten its mojo back after being roiled by the global economic crisis. The industry enjoyed a positive run this year, helped by an upswing in the world economy and strength...

Zacks Investment Research
8 Big Banks Get Fed Regulators Approval On 'Living Wills' By Zacks Investment Research - Dec 20, 2017

On Tuesday, U.S. banking regulators — the Federal Reserve and the Federal Deposit Insurance Corp (“FDIC”) — passed eight largest domestic banking organizations on their "living...

Zacks Investment Research
Why These 3 Underperformers May Rebound In 2018 By Zacks Investment Research - Dec 20, 2017

Market performance has been exceptionally well this year with the major indexes touching record highs several times. So far, the S&P 500, Dow Jones Industrial Average and Nasdaq Composite index...

Zacks Investment Research
3 Leveraged Large Cap ETFs To Play The Bull Market By Zacks Investment Research - Dec 20, 2017

U.S. equities have had a stellar run on robust growth and rising optimism around President Donald Trump’s tax reform.Senate Passes GOP Tax Bill The Senate passed the GOP tax bill just after...

Zacks Investment Research
Pfizer's Leukemia Drug Gets FDA Nod In First-Line Setting By Zacks Investment Research - Dec 20, 2017

Pfizer, Inc. (NYSE:PFE) announced that the FDA has approved its leukemia drug, Bosulif in first-line setting.We remind investors that Bosulif is currently approved for the treatment of chronic,...

Edison
Borussia Dortmund: Christmas Comes Early   By Edison - Dec 20, 2017

Borussia Dortmund GmbH & Co KGaA (SIX:BVB): Immediate back-to-back Bundesliga wins under new coach Peter Stöger is at least a welcome change of fortune for beleaguered Dortmund. Now the...

Alan Bradley
NFLX Chart Not Giving Any Clues Just Yet By Alan Bradley - Dec 20, 2017

Netflix Inc (NASDAQ:NFLX) has enjoyed an awesome run in its two year red line ascension channel. Several weeks ago, when the short term red channel intersected the long term blue channel, the price...

Jani Ziedins
S&P 500 Struggling To Go Higher On Good News By Jani Ziedins - Dec 20, 2017

The S&P 500 stumbled on Tuesday as Congress moved closer to approving Tax Reform. The joint tax bill sailed through the House with plenty of room to spare, but a technicality means they will need...

Alan Bradley
GOOGL Chart Mirroring FB By Alan Bradley - Dec 20, 2017

Alphabet Inc Class A (NASDAQ:GOOGL) chart is experiencing the almost identical technical situation as Facebook Inc (NASDAQ:FB) whereby it is trying to assert its red short term channel as being...

Alan Bradley
FB Wrestling Between Long Term And Mid Term Channels By Alan Bradley - Dec 20, 2017

Facebook Inc (NASDAQ:FB) has had an impressive climb over the past five years. Over the past six months, its steep inner ascension channel (shown with red lines) has actually gotten above its long...

Alan Bradley
AMZN May Be Getting Toppy By Alan Bradley - Dec 20, 2017

Amazon.com's (NASDAQ:AMZN) weekly chart is quite a specimen as it has quadrupled from 300 to 1200 in three years. Typically after a big stock has had such a massive run a breakout above its upper...

Continue with Apple
Continue with Google
or
Sign up with Email